Sevoflurane preconditioning-induced neuroprotection is associated with Akt activation via carboxy-terminal modulator protein inhibition

British Journal of Anaesthesia

Volumn 114, Issue 2, 2015, Pages 327-335

  Chen, Y ^a   Nie, H ^a   Tian, L ^a   Tong, L ^a   Deng, J ^a   Zhang, Y ^a   Dong, H ^a   Xiong, L ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

preconditioning

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CARBOXY TERMINAL MODULATOR PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; LENTIVIRUS VECTOR; PROTEIN; PROTEIN KINASE B; SEVOFLURANE; UNCLASSIFIED DRUG; WORTMANNIN; CARRIER PROTEIN; CTMP PROTEIN, RAT; ETHER DERIVATIVE; GLYCOGEN SYNTHASE KINASE 3; INHALATION ANESTHETIC AGENT; NEUROPROTECTIVE AGENT; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN REGION; ENZYME ACTIVATION; ENZYME ACTIVITY; IN VIVO STUDY; MALE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; VIRAL GENE DELIVERY SYSTEM; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC PRECONDITIONING; METABOLIC ACTIVATION; METABOLISM; PROCEDURES; PSYCHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ACTIVATION, METABOLIC; ANESTHETICS, INHALATION; ANIMALS; BEHAVIOR, ANIMAL; CARRIER PROTEINS; GLYCOGEN SYNTHASE KINASE 3; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC PRECONDITIONING; MALE; METHYL ETHERS; NEUROPROTECTIVE AGENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84922546701     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeu271     Document Type: Article

References (44)

1. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372: 139-44
2. Xiong L, Zheng Y, Wu M, et al. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesth Analg 2003; 96: 233-7
3. ZhengS, Zuo Z. Isofluranepreconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Mol Pharmacol 2004; 65: 1172-80
4. McMurtrey RJ, Zuo Z. Isoflurane preconditioning and postconditioning in rat hippocampal neurons. Brain Res 2010; 1358: 184-90
5. Adamczyk S, Robin E, Simerabet M, et al. Sevoflurane pre- and postconditioning protect the brain via the mitochondrial K ATP channel. Br J Anaesth 2010; 104: 191-200
6. Codaccioni JL, Velly LJ, Moubarik C, Bruder NJ, Pisano PS, Guillet BA. Sevoflurane preconditioning against focal cerebral ischemia: inhibition of apoptosis in the face of transient improvement of neurological outcome. Anesthesiology 2009; 110: 1271-8
7. Ding Q, Wang Q, Deng J, et al. Sevoflurane preconditioning induces rapid ischemic tolerance against spinal cord ischemia/reperfusion through activation of extracellular signal-regulated kinase in rabbits. Anesth Analg 2009; 109: 1263-72
8. Wang S, Dai ZG, Dong XW, et al. Duplicate preconditioning with sevoflurane in vitro improves neuroprotection in rat brain via activating the extracellular signal-regulated protein kinase. Neurosci Bull 2010; 26: 437-44
9. Brywe KG, Mallard C, Gustavsson M, et al. IGF-I neuroprotection in the immature brain after hypoxia-ischemia, involvement of Akt and GSK3beta? Eur J Neurosci 2005; 21: 1489-502
10. Brywe KG, Leverin AL, Gustavsson M, et al. Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3beta phosphorylation. Endocrinology 2005; 146: 4665-72
11. Han BH, Holtzman DM. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci 2000; 20: 5775-81
12. Bhuiyan MI, Jung SY, Kim HJ, Lee YS, Jin C. Major role of the PI3K/Akt pathway in ischemic tolerance induced by sublethal oxygenglucose deprivation in cortical neurons in vitro. Arch Pharm Res 2011; 34: 1023-34
13. Abe E, Fujiki M, Nagai Y, et al. The phosphatidylinositol-3 kinase/Akt pathway mediates geranylgeranylacetone-induced neuroprotection against cerebral infarction in rats. Brain Res 2010; 1330: 151-7
14. Hanada M, Feng J, Hemmings BA. Structure, regulation and function of PKB/AKT-a major therapeutic target. Biochim Biophys Acta 2004; 1697: 3-16
15. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C. PI3K/Aktand apoptosis: size matters. Oncogene 2003; 22: 8983-98
16. Maira SM, Galetic I, Brazil DP, et al. Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane. Science (New York, NY) 2001; 294: 374-80
17. Miyawaki T, Ofengeim D, Noh KM, et al. The endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced neuronal death. Nat Neurosci 2009; 12: 618-26
18. Wang JK, Yu LN, Zhang FJ, et al. Postconditioning with sevoflurane protects against focal cerebral ischemia and reperfusion injury via PI3K/Akt pathway. Brain Res 2010; 1357: 142-51
19. Zhang QG, Han D, Xu J, et al. Ischemic preconditioning negatively regulates plenty of SH3s-mixed lineage kinase 3-Rac1 complex and c-Jun N-terminal kinase 3 signaling via activation of Akt. Neuroscience 2006; 143: 431-44
20. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91
21. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke1995;26:627-34; discussion35
22. Swanson RA, Sharp FR. Infarct measurement methodology. J Cereb Blood Flow Metab 1994; 14: 697-8
23. Chen Y, Nie H, Tian L, et al. Nicotine-induced neuroprotection against ischemic injury involves activation of endocannabinoid system in rats. Neurochem Res 2013; 38: 364-70
24. Ashwal S, Tone B, Tian HR, Cole DJ, PearceWJ. Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke 1998; 29: 1037-46; discussion 47
25. Zhao H, Shimohata T, Wang JQ, et al. Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 2005; 25: 9794-806
26. Wang F, Xu L, Guo C, et al. Identification of RegIV as a novel GLI1 target gene in human pancreatic cancer. PLoS One 2011; 6: e18434
27. Sang H, Cao L, Qiu P, Xiong L, Wang R, Yan G. Isoflurane produces delayed preconditioning against spinal cord ischemic injury via release of free radicals in rabbits. Anesthesiology 2006; 105: 953-60
28. Liu Y, Xiong L, Chen S, Wang Q. Isoflurane tolerance against focal cerebral ischemia is attenuated by adenosine A1 receptor antagonists. Can J Anaesth 2006; 53: 194-201
29. Li QF, Zhu YS, Jiang H. Isoflurane preconditioning activates HIF-1alpha, iNOS and Erk1/2 and protects against oxygen-glucose deprivation neuronal injury. Brain Res 2008; 1245: 26-35
30. Yang Q, Dong H, Deng J, et al. Sevoflurane preconditioning induces neuroprotection through reactive oxygen species-mediated up-regulation of antioxidant enzymes in rats. Anesth Analg 2011; 112: 931-7
31. Bedirli N, Bagriacik EU, Emmez H, Yilmaz G, Unal Y, Ozkose Z. Sevoflurane and isoflurane preconditioning provides neuroprotection by inhibition of apoptosis-related mRNA expression in a rat model of focal cerebral ischemia. J Neurosurg Anesthesiol 2012; 24: 336-44
32. Velly LJ, Canas PT, Guillet BA, et al. Earlyanestheticpreconditioning in mixedcorticalneuronal-glial cellcultures subjectedtooxygen-glucose deprivation: the role of adenosine triphosphate dependent potassium channels and reactive oxygen species in sevoflurane-induced neuroprotection. Anesth Analg 2009; 108: 955-63
33. Kehl F, Payne RS, Roewer N, Schurr A. Sevoflurane-induced preconditioning of rat brain in vitro and the role ofKATPchannels. Brain Res 2004; 1021: 76-81
34. Ye Z, Huang YM, Wang E, Zuo ZY, Guo QL. Sevoflurane-induced delayed neuroprotection involves mitoK(ATP) channel opening and PKC epsilon activation. Mol Biol Rep 2012; 39: 5049-57
35. Wang L, Traystman RJ, Murphy SJ. Inhalational anesthetics as preconditioning agents in ischemic brain. Curr Opin Pharmacol 2008; 8: 104-10
36. Onishi A, Miyamae M, Kaneda K, Kotani J, Figueredo VM. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A. Eur J Pharmacol 2012; 675: 40-6
37. Mottet D, Dumont V, Deccache Y, et al. Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells. J Biol Chem 2003; 278: 31277-85
38. Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate. J Biol Chem 1998; 273: 13375-8
39. Gao X, Zhang H, Takahashi T, et al. The Akt signaling pathway contributes to postconditionings protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem 2008; 105: 943-55
40. Baba T, Kameda M, Yasuhara T, et al. Electrical stimulation of the cerebral cortex exerts antiapoptotic, angiogenic, and anti-inflammatory effects in ischemic stroke rats through phosphoinositide 3-kinase/Akt signaling pathway. Stroke 2009; 40: e598-605
41. Zhou Y, Fathali N, Lekic T, et al. Remote limbischemic postconditioning protects against neonatal hypoxic-ischemic brain injury in ratpupsby theopioidreceptor/Aktpathway. Stroke2011;42:439-44
42. Luo Y, Ma D, Ieong E, et al. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology 2008; 109: 782-9
43. Wagner C, Tillack D, Simonis G, Strasser RH, Weinbrenner C. Ischemic post-conditioning reduces infarct size of the in vivo rat heart: role of PI3-K, mTOR, GSK-3beta, and apoptosis. Mol Cell Biochem 2010; 339: 135-47
44. Lin HY, Wu CL, Huang CC. The Akt-endothelial nitric oxide synthase pathway in lipopolysaccharide preconditioning-induced hypoxicischemic tolerance in the neonatal rat brain. Stroke 2010; 41: 1543-51